Q3 FY26 results: Standalone loss, strong consolidated growth; CS exits

Revenue Growth 20pctPat Growth 25pctPat NegativeRelated Party TransactionsResults View source PDF Explain this filing

FISCHER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹38.67

prior close

₹37.39

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%-4.5% vs market

Medical Equipment & Supplies peers, median of 12sector-0.5%-5.3% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 5.3 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.5

15m

-0.6

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8-1.3-4.5-0.5-5.3

Next day

-0.8+2.4-3.2+2.7-3.5

+4.1+3.8+0.4+1.9+2.3

+9.1+2.7+6.4+1.3+7.8

+14.1+1.9+12.2+1.4+12.8

+17.8+4.6+13.3+3.6+14.2

+9.6+5.1+4.6+1.4+8.2

15d

+7.4+2.1+5.4+3.4+4.1

-2.8-2.1-0.7-1.2-1.6

+6.0-6.4+12.5-11.8+17.8

-1.9+9.5-11.5+1.1-3.0

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Standalone Q3 loss of Rs 166.93 lakhs on revenue of Rs 131.50 lakhs. Consolidated 9M revenue nearly tripled to Rs 21,084.52 lakhs with PAT at Rs 3,813.89 lakhs versus a loss of Rs 10.42 lakhs year ago. Company Secretary Aravindkumar V resigns effective Feb 10 for personal reasons. Malaysian subsidiary FHSB to be restructured with trustee holding 51 percent on company behalf. Company also fined by exchanges for delayed related party transaction filing.

Likely market impact

Mixed picture: strong consolidated growth offsets standalone weakness. CS exit and compliance penalty may cause short-term governance concerns for shareholders.